Financial Framework 2025-26
On 30th June 2025, the Community Pharmacy Scotland (CPS) Board was informed that a 4% uplift will be applied to the Global Sum for 2025/26, amounting to approximately £9.31 million in total. This year’s deal was agreed in two parts, with Part One finalised and accepted on 1st May 2025. Part One outlined the mapping of £20 million from the Drug Tariff to support key funding lines, along with a £10 million increase in the Guaranteed Minimum that can be retained from the Drug Tariff, bringing it to £120 million. This funding will be used directly to support additional costs faced by the network, such as the impact of National Insurance contributions.
Please note: The package sets out a defined amount of funding (remuneration) available for the provision of core services, referred to as the Global Sum, from which all contractors will benefit. We explain these funding "pots" below.
There are, however, small elements of national funding that fall outside the Global Sum. For example, not all contractors will utilise arrangements for stoma dispensing or access to Medicines Complete, which are technically standalone contracts. Collectively, we refer to these as the Non-Global Sum.
The financial package also outlines the arrangements for the Reimbursement element of the annual agreement—specifically, the conditions surrounding income generated from purchasing certain medicines at a lower cost than the NHS reimbursement price.
Please see below for a breakdown of each element:
Advance payments are made to support contractor cashflow while actual payment for the prescriptions submitted is calculated.